Matching geography Reports matching your search in: Join Alert Me now! Receive bi-weekly email alerts on new market research Sign up today!
|
Pharmaceuticals: market research reports
Pharmaceuticals market research reports and industry analysis
Mundipharma International Limited – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
|
read more...
|
$1,500.00
|
Wilex AG – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Wilex AG’s corporate ...
|
read more...
|
$1,500.00
|
Momenta Pharmaceuticals, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
|
read more...
|
$1,500.00
|
MacroGenics, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MacroGenics, Inc.’s corporate ...
|
read more...
|
$1,500.00
|
Generex Biotechnology Corporation – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
|
read more...
|
$1,500.00
|
Cytokinetics, Incorporated – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Cytokinetics, Incorporated’s corporate ...
|
read more...
|
$1,500.00
|
ImmunoGen, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ImmunoGen, Inc.’s corporate ...
|
read more...
|
$1,500.00
|
BioMarin Pharmaceutical Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
|
read more...
|
$1,500.00
|
Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ...
|
read more...
|
$1,500.00
|
Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
|
read more...
|
$1,500.00
|
CanBas Co., Ltd. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
|
read more...
|
$1,500.00
|
Iron Deficiency Anemia – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Iron Deficiency Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia. Iron Deficiency Anemia ...
|
read more...
|
$2,000.00
|
CytRx Corporation – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, CytRx Corporation’s corporate ...
|
read more...
|
$1,500.00
|
|
|
$4,450.00
|
Skin Ulcers – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... for Skin Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin Ulcers. Skin Ulcers - Pipeline Review, Half Year ...
|
read more...
|
$2,000.00
|
|
|
$4,450.00
|
|
|
$2,995.00
|
Motor Neurone Diseases – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Motor Neurone Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Motor Neurone Diseases. Motor Neurone Diseases ...
|
read more...
|
$2,000.00
|
Sanofi – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Sanofi’s corporate website, SEC filings, investor ...
|
read more...
|
$1,500.00
|
NPS Pharmaceuticals, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
|
read more...
|
$1,500.00
|
|
|
$1,500.00
|
Advaxis, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Advaxis, Inc.’s corporate ...
|
read more...
|
$1,500.00
|
|
|
$5,995.00
|
Astellas Pharma Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...
|
read more...
|
$1,500.00
|
Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... provides information on the therapeutic development for Metastatic Adenocarcinoma of The Pancreas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ...
|
read more...
|
$2,000.00
|
|